AMPK Regulation of ACE2 in Endothelial Health and Disease
AMPK 在内皮健康和疾病中对 ACE2 的调节
基本信息
- 批准号:10568995
- 负责人:
- 金额:$ 67.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoV5&apos-AMP-activated protein kinaseACE2AccelerationAffectAngiotensin IIAngiotensinsAnimal ModelArterial LinesAtherosclerosisBindingBiologyCOVID-19Cardiovascular DiseasesCell physiologyCellsCellular Metabolic ProcessCellular biologyCuesDiseaseEndothelial CellsEndotheliumFunctional disorderGlycolysisGoalsHealthHeart DiseasesHomeostasisImpairmentIn VitroInflammationInvadedLeadLinkLong-Term EffectsMembraneMetforminMolecularMutant Strains MiceOrganellesOxidation-ReductionPhosphorylationPhosphotransferasesPhysiologicalPlayPost-Acute Sequelae of SARS-CoV-2 InfectionProliferatingProtein KinaseProteinsRegulationRenin-Angiotensin-Aldosterone SystemReporterResearchRisk FactorsRoleSARS coronavirusSARS-CoV-2 infectionSARS-CoV-2 spike proteinSignal TransductionStimulusStressTestingUp-RegulationVascular Endothelial CellVascular EndotheliumVasodilationViralVirusangiogenesisarmatheroprotectivecardiovascular healthcell injurycell typeenergy balanceextracellularfunctional outcomesin vivoinnovationinsightinterestlive cell imaginglong term consequences of COVID-19mechanotransductionmouse modelnovelpharmacologicshear stressspatiotemporaltoolupstream kinase
项目摘要
Project Summary
Vascular endothelial cell (EC) metabolism is essential for functional endothelium, and maladapted energy use
severely affects EC health. AMP-activated protein kinase (AMPK) is a key regulator of cellular energy status and
homeostatic function. Our preliminary studies showed that energy stress results in spatially defined AMPK
activity at cellular organelles, which indicates that AMPK activity is compartmentalized in the cell. An emerging
AMPK substrate in the vascular endothelium is angiotensin-converting enzyme 2 (ACE2), and we have found
that the AMPK–ACE2 axis enhances EC function and is atheroprotective. SARS-CoV viruses invade the host
cells by binding the viral spike protein (S protein) to ACE2, which leads to decreased membrane ACE2 levels,
increased extracellular soluble ACE2, and increased glycolysis, thus resulting in host cell damage. In preliminary
studies, we have also found that the SARS-CoV-2 S protein deactivates the AMPK–ACE2 axis and impairs EC
function in vitro and in vivo. This impairment is likely to constitute a risk factor for the long-term effects of SARS-
CoV-2 infection or post-acute sequelae of SARS-CoV-2 infection (PASC). These preliminary findings lead to the
hypothesis that EC homeostasis is maintained via the spatiotemporal regulation of the AMPK–ACE2 axis. In
contrast, S protein entry disrupts cellular energetics in ECs, leading to dysregulated AMPK and the ensuing
ACE2 hypo-phosphorylation, which critically contributes to the COVID-19–associated EC dysfunction and PASC.
The three specific aims proposed to test this novel hypothesis are as follows: Aim 1. To investigate the
spatiotemporal regulation of AMPK in ECs under physiological [e.g., pulsatile shear stress (PS)],
pharmacological (e.g., metformin), and pathophysiological (e.g., S protein) conditions; Aim 2. To decipher the
mechanisms by which physiological, pharmacological, and pathophysiological stimuli modulate the AMPK–
ACE2 axis in ECs; Aim 3. To investigate the role of impaired AMPK–ACE2 axis in S protein-accelerated
atherosclerosis in the context of PASC. In the proposed research, we will use live cell imaging, in vitro EC biology,
and in vivo animal models to determine the role of the AMPK–ACE2 axis in endothelial health and disease.
These findings will result in otherwise missing insights into the pathophysiology of PASC, which will continue to
be a long-term consequence of SARS-CoV-2 infection.
项目概要
血管内皮细胞 (EC) 代谢对于功能性内皮细胞和不适应的能量使用至关重要
严重影响 EC 健康。AMP 激活蛋白激酶 (AMPK) 是细胞能量状态的关键调节因子。
我们的初步研究表明,能量应激会导致空间定义的 AMPK。
细胞器中的活性,这表明 AMPK 活性在细胞中是划分的。
血管内皮中的AMPK底物是血管紧张素转换酶2(ACE2),我们发现
AMPK-ACE2 轴增强 EC 功能并对 SARS-CoV 病毒入侵宿主具有保护作用。
通过将病毒刺突蛋白(S 蛋白)与 ACE2 结合,导致细胞膜 ACE2 水平降低,
细胞外可溶性ACE2增加,糖酵解增加,从而初步导致宿主细胞损伤。
研究中,我们还发现 SARS-CoV-2 S 蛋白会使 AMPK-ACE2 轴失活并损害 EC
这种损伤可能构成 SARS 长期影响的危险因素。
这些初步发现导致了 CoV-2 感染或 SARS-CoV-2 感染的急性后遗症(PASC)。
假设 EC 稳态是通过 AMPK-ACE2 轴的时空调节来维持的。
相比之下,S 蛋白的进入会破坏 EC 中的细胞能量,导致 AMPK 失调以及随之而来的
ACE2 低磷酸化,对 COVID-19 相关的 EC 功能障碍和 PASC 起着至关重要的作用。
为检验这一新假设而提出的三个具体目标如下: 目标 1. 调查
生理条件下 EC 中 AMPK 的时空调节 [例如,脉动剪切应力 (PS)],
药理学(例如二甲双胍)和病理生理学(例如 S 蛋白)条件; 目标 2. 破译
生理学、药理学和病理生理学刺激调节 AMPK 的机制
EC 中的 ACE2 轴;目标 3. 研究受损的 AMPK-ACE2 轴在 S 蛋白加速中的作用
PASC 背景下的动脉粥样硬化 在拟议的研究中,我们将使用活细胞成像、体外 EC 生物学、
以及体内动物模型,以确定 AMPK-ACE2 轴在内皮健康和疾病中的作用。
这些发现将导致人们对 PASC 病理生理学的认识缺失,而 PASC 的病理生理学将继续
是 SARS-CoV-2 感染的长期后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John YJ Shyy其他文献
John YJ Shyy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John YJ Shyy', 18)}}的其他基金
AMPK Regulation of ACE2 in Endothelial Health and Disease
AMPK 在内皮健康和疾病中对 ACE2 的调节
- 批准号:
10391055 - 财政年份:2022
- 资助金额:
$ 67.31万 - 项目类别:
Flow-Induced Endothelial Innate Immunity and Atherosclerosis Susceptibility
血流诱导的内皮先天免疫和动脉粥样硬化易感性
- 批准号:
9185542 - 财政年份:2016
- 资助金额:
$ 67.31万 - 项目类别:
Flow-Induced Endothelial Innate Immunity and Atherosclerosis Susceptibility
血流诱导的内皮先天免疫和动脉粥样硬化易感性
- 批准号:
9751360 - 财政年份:2016
- 资助金额:
$ 67.31万 - 项目类别:
The miRNA-mediated Translational De-suppression in Hypoxic Endothelium
缺氧内皮细胞中 miRNA 介导的翻译去抑制
- 批准号:
8534808 - 财政年份:2012
- 资助金额:
$ 67.31万 - 项目类别:
The miRNA-mediated Translational De-suppression in Hypoxic Endothelium
缺氧内皮细胞中 miRNA 介导的翻译去抑制
- 批准号:
8716847 - 财政年份:2012
- 资助金额:
$ 67.31万 - 项目类别:
The miRNA-mediated Translational De-suppression in Hypoxic Endothelium
缺氧内皮细胞中 miRNA 介导的翻译去抑制
- 批准号:
8716847 - 财政年份:2012
- 资助金额:
$ 67.31万 - 项目类别:
Shear stress, SIRT1, and Arterial Stiffening
剪切应力、SIRT1 和动脉硬化
- 批准号:
8145200 - 财政年份:2010
- 资助金额:
$ 67.31万 - 项目类别:
相似国自然基金
晚期妊娠维持和抑制早产中cAMP信号活化PR的作用机制研究
- 批准号:81300507
- 批准年份:2013
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Endothelial Metabolic Reprogramming by Interferon-gamma in Coronary Artery Disease
干扰素γ在冠状动脉疾病中的内皮代谢重编程
- 批准号:
10662850 - 财政年份:2023
- 资助金额:
$ 67.31万 - 项目类别:
Elucidating the Trophic Support of Long Axons by Metabolic Signaling in Oligodendrocytes
通过少突胶质细胞代谢信号阐明长轴突的营养支持
- 批准号:
10782630 - 财政年份:2023
- 资助金额:
$ 67.31万 - 项目类别:
Glyoxalase 1 and its Role in Metabolic Syndrome
乙二醛酶 1 及其在代谢综合征中的作用
- 批准号:
10656054 - 财政年份:2023
- 资助金额:
$ 67.31万 - 项目类别:
Development of caspase-6 inhibitors for treatment of NASH
开发治疗 NASH 的 caspase-6 抑制剂
- 批准号:
10608905 - 财政年份:2023
- 资助金额:
$ 67.31万 - 项目类别: